Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      LifeCell ties-up with Cryo-Save India for preserved umbilical cord stem cell samples

      LifeCell ties-up with Cryo-Save India for preserved umbilical cord stem cell samples

      Ruby Khatun Khatun11 Oct 2017 9:58 AM IST
      Chennai: LifeCell announced the signing of a formal agreement with Cryo-Save India (Cryo-Save) for the formal transfer of all of its 18,000...
      FDA awards six grants for natural history studies in rare diseases

      FDA awards six grants for natural history studies in rare diseases

      Ruby Khatun Khatun11 Oct 2017 9:01 AM IST
      The U.S. Food and Drug Administration (FDA) announced it has awarded six new research grants for natural history studies in rare diseases. The aim of...
      Aakash plans to raise Rs 1,000 crore via IPO

      Aakash plans to raise Rs 1,000 crore via IPO

      Ruby Khatun Khatun10 Oct 2017 5:49 PM IST
      New Delhi: Aakash Education Services Pvt. Ltd. (AESPL), a Delhi based coaching company known for training medical and engineering aspirants for...
      Marksans Pharma gets EIR from USFDA for its Goa facility

      Marksans Pharma gets EIR from USFDA for its Goa facility

      Ruby Khatun Khatun10 Oct 2017 11:17 AM IST
      New Delhi: Drug firm Marksans Pharma said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.The...
      FDA approves implantable device to treat moderate to severe central sleep apnea

      FDA approves implantable device to treat moderate to severe central sleep apnea

      Ruby Khatun Khatun10 Oct 2017 10:50 AM IST
      The U.S. Food and Drug Administration (FDA) approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep...
      Zydus Cadila gets USFDA nod to market antidepressant drug

      Zydus Cadila gets USFDA nod to market antidepressant drug

      Ruby Khatun Khatun10 Oct 2017 10:30 AM IST
      New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Amitriptyline hydrochloride tablets used for the...
      Indias first global consortium to unveil collective diagnostic strength  of four countries

      Indias first global consortium to unveil collective diagnostic strength of four countries

      Ruby Khatun Khatun10 Oct 2017 10:30 AM IST
      Bangalore: Aggregating the fragmented diagnostic sector of the country, four nations joined forces to launch India’s first global Pathology Laboratory...
      Amazon is headed for the prescription-drug market, analysts say

      Amazon is headed for the prescription-drug market, analysts say

      Ruby Khatun Khatun10 Oct 2017 10:01 AM IST
      Amazon.com Inc. is almost certain to enter the business of selling prescription drugs by 2019, said two analysts at Leerink Partners, posing a direct...
      HC asks Centre, Maharashtra to list steps taken to regulate online medicine sale

      HC asks Centre, Maharashtra to list steps taken to regulate online medicine sale

      Ruby Khatun Khatun9 Oct 2017 12:38 PM IST
      MUMBAI: Expressing concern over the rampant unauthorized sale of medicines online, the Bombay High Court has asked the Maharashtra government and the...
      Shilpa Medicare gets EIR from USFDA for Jadcherla facility

      Shilpa Medicare gets EIR from USFDA for Jadcherla facility

      Ruby Khatun Khatun9 Oct 2017 10:44 AM IST
      New Delhi: Shilpa Medicare on Saturday said the USFDA has issued an Establishment Inspection Report (EIR) for its Jadcherla facility in Telangana.The...
      Baba Ramdevs Patanjali Ayurved planning to invest Rs 5,000 crore this fiscal

      Baba Ramdevs Patanjali Ayurved planning to invest Rs 5,000 crore this fiscal

      Ruby Khatun Khatun9 Oct 2017 10:38 AM IST
      INDORE: Patanjali Ayurved's managing director Balkrishna said here that the company is planning to invest Rs 5,000 crore in the country in the current...
      Medical devices park: AP Govt calls for fresh tender

      Medical devices park: AP Govt calls for fresh tender

      Ruby Khatun Khatun9 Oct 2017 10:16 AM IST
      VISAKHAPATNAM: The Andhra Pradesh Government has called for a fresh tender for the medical devices park coming up in Visakhapatnam district -...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok